These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9131796)

  • 21. Occurrence of K1, K5 and O antigens in Escherichia coli isolates from patients with urinary tract infections or bacteraemia.
    Devine DA; Robinson L; Roberts AP
    J Med Microbiol; 1989 Dec; 30(4):295-9. PubMed ID: 2481040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An outer membrane-disorganizing peptide PMBN sensitizes E. coli strains to serum bactericidal action.
    Vaara M; Viljanen P; Vaara T; Mäkelä PH
    J Immunol; 1984 May; 132(5):2582-9. PubMed ID: 6325539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunochemical investigations on lipopolysaccharides and acidic polysaccharides from serum-sensitive and serum-resistant strains of Escherichia coli isolated from urinary-tract infections.
    Taylor PW
    J Med Microbiol; 1976 Nov; 9(4):405-21. PubMed ID: 794476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Murine hybridoma antibodies enhance bactericidal activity of human cord blood against K1 Escherichia coli strains.
    Kim KS; Cross AS; Kaufmann B; Zollinger W; Sadoff J
    Pediatr Res; 1990 Dec; 28(6):667-70. PubMed ID: 1704500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uropathogenic properties of Escherichia coli in recurrent urinary-tract infection.
    Brooks HJ; O'Grady F; McSherry MA; Cattell WR
    J Med Microbiol; 1980 Feb; 13(1):57-68. PubMed ID: 6102156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of alpha-haemolysin in resistance of Escherichia coli strains to bactericidal action of human serum and polymorphonuclear leukocytes.
    Siegfried L; Filka J; Puzová H
    Adv Exp Med Biol; 1995; 371A():691-3. PubMed ID: 8526020
    [No Abstract]   [Full Text] [Related]  

  • 27. Logarithmic phase Escherichia coli K1 efficiently avoids serum killing by promoting C4bp-mediated C3b and C4b degradation.
    Wooster DG; Maruvada R; Blom AM; Prasadarao NV
    Immunology; 2006 Apr; 117(4):482-93. PubMed ID: 16556262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitivity of some smooth strains of Escherichia coli to the bactericidal action of normal human serum.
    Taylor PW
    J Clin Pathol; 1974 Aug; 27(8):626-9. PubMed ID: 4608427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. K1, K5 and O antigens of Escherichia coli in relation to serum killing via the classical and alternative complement pathways.
    Devine DA; Roberts AP
    J Med Microbiol; 1994 Aug; 41(2):139-44. PubMed ID: 7519270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of growth temperature of Escherichia coli on K1 capsular antigen production and resistance to opsonization.
    Bortolussi R; Ferrieri P; Quie PG
    Infect Immun; 1983 Mar; 39(3):1136-41. PubMed ID: 6341228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of subinhibitory concentrations of mecillinam on the serum susceptibility of Escherichia coli strains.
    Taylor PW; Gaunt H; Unger FM
    Antimicrob Agents Chemother; 1981 May; 19(5):786-8. PubMed ID: 6271047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ozone as sensitizer of bacteria to the bactericidal action of complement.
    Doroszkiewicz W; Sikorska I; Jankowski S
    Acta Microbiol Pol; 1993; 42(3-4):315-9. PubMed ID: 7516620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Escherichia coli K1 in urinary tract infections.
    Reina J; Salva F; Gil J; Alomar P
    Eur J Clin Microbiol Infect Dis; 1988 Apr; 7(2):205. PubMed ID: 3134218
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of CD14 in responses to clinical isolates of Escherichia coli: effects of K1 capsule expression.
    Metkar S; Awasthi S; Denamur E; Kim KS; Gangloff SC; Teichberg S; Haziot A; Silver J; Goyert SM
    Infect Immun; 2007 Nov; 75(11):5415-24. PubMed ID: 17709409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum resistance of Escherichia coli strains causing urinary tract infection and diarrhoea in relation to alpha haemolysin production and O type.
    Rizvi M; Kumar S
    Indian J Pathol Microbiol; 2003 Jul; 46(3):504-6. PubMed ID: 15025325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibody 2-2-B kills K1-positive Escherichia coli in conjunction with cord blood neutrophils and sera, but not with spinal fluid.
    Cross AS; Wooldridge WH; Zollinger WD
    Pediatr Res; 1984 Aug; 18(8):770-2. PubMed ID: 6382138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interaction of cefotaxime and normal human serum in the bacteriocidal process against strains of Escherichia coli producing surface K1 antigen].
    Franiczek R; Jankowski S
    Med Dosw Mikrobiol; 1993; 45(1):61-4. PubMed ID: 8231445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of E. coli strains with human serum: lack of relationship to K1 antigen.
    Björkstén B; Bortolussi R; Gothefors L; Quie PG
    J Pediatr; 1976 Dec; 89(6):892-7. PubMed ID: 792409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. O, K, and H antigens predict virulence factors, carboxylesterase B pattern, antimicrobial resistance, and host compromise among Escherichia coli strains causing urosepsis.
    Johnson JR; Orskov I; Orskov F; Goullet P; Picard B; Moseley SL; Roberts PL; Stamm WE
    J Infect Dis; 1994 Jan; 169(1):119-26. PubMed ID: 7506278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Escherichia coli K antigen in relation to serum-induced lysis and phagocytosis.
    Van Dijk WC; Verbrugh HA; Peters R; Van Der Tol ME; Peterson PK; Verhoef J
    J Med Microbiol; 1979 Feb; 12(1):123-30. PubMed ID: 372531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.